|
||||||||||||||||||||||
General Assembly Invitation
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Agenda Items
|
||||||||||||||||||||||
1 - Opening and forming of the Presidential Board and to authorize the Presidential Board to sign the meeting minutes and its annexes
|
||||||||||||||||||||||
2 - Review, discussion, and approval of the Annual Report of the Board of Directors of the year 2023
|
||||||||||||||||||||||
3 - Review, discussion, and approval of the summary statement of the Independent Audit Report of the fiscal year 2023
|
||||||||||||||||||||||
4 - Review, discussion, and approval of the year-end Financial Statements for the fiscal year 2023
|
||||||||||||||||||||||
5 - Releasing severally the Members of the Board from their activities for the year 2023
|
||||||||||||||||||||||
6 - Approval, approval with amendment, or rejection of the Board of Directors' proposal to the General Assembly that there will not be a dividend distribution for the year 2023 in accordance with the Dividend Policy of our Company
|
||||||||||||||||||||||
7 - Submitting for the approval of the General Assembly the Remuneration Policy pursuant to the regulations of the Capital Markets Board
|
||||||||||||||||||||||
8 - Electing new Board members including the independent members in place of the board members whose duties period will be expired and to determine the duties' period of the new board members
|
||||||||||||||||||||||
9 - Determining the rights of the members of the Board of Directors regarding the wages and attendance fee, and rights such as bonus, premium
|
||||||||||||||||||||||
10 - Discussion and approval of the nomination of the Independent Audit Company conducted by the Board of Directors pursuant to the Turkish Commercial Code and the regulations of the Capital Markets Board
|
||||||||||||||||||||||
11 - Giving information to the General Assembly on the donations and aids which were provided by the Company in 2023 and determining the upper limit of donation to be made in the year 2024
|
||||||||||||||||||||||
12 - Approval of the General Assembly regarding the Company's initiative to establish a Foundation to carry out its donation and aid activities
|
||||||||||||||||||||||
13 - Giving information to the General Assembly regarding the transactions of the "Related Parties" as per third section of Corporate Governance Communique (II-17.1) of the Capital Markets Board
|
||||||||||||||||||||||
14 - Giving information to the General Assembly regarding pledges, collaterals, and mortgages to the shareholders as per fourth section of Corporate Governance Communique (II-17.1) of the Capital Markets Board
|
||||||||||||||||||||||
15 - Authorization of the shareholders that have management control, the members of the Board of Directors, the senior executives and their spouses and relatives related by blood or affinity up to the second degree as per the provisions of articles 395 and 396 of the Turkish Commercial Code and presentation to the shareholders of the transactions carried out thereof in the year 2023 pursuant to the Corporate Governance Communique of the Capital Markets Board
|
||||||||||||||||||||||
16 - Wishes and requests
|
||||||||||||||||||||||
17 - Closing
|
||||||||||||||||||||||
Corporate Actions Involved In Agenda
|
||||||||||||||||||||||
|
||||||||||||||||||||||
General Assembly Results
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Decisions Regarding Corporate Actions
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Additional Explanations
|
||||||||||||||||||||||
|
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.